1. New Approved Treatment and Indications in Oncology
The year 2018 reflect the continued growth in new drug approvals by the US Food and Drug Administration that has been seen over the past few years. more details...


2. FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot bemore details...